SEC Form 4 · accession 0001127602-15-034574
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas F Ackerman
Other
Period of report
Dec 17, 2015
Accepted (ET)
Dec 18, 2015 · 1:57 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 17, 2015 | M | 10,000 | $37.03 | A | 110,635 | D | |
| Common Stock | Dec 17, 2015 | S | 10,000 | $80.00 | D | 100,635 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) | $37.03 | Dec 17, 2015 | M | 10,000 | D | Feb 25, 2012 | Feb 25, 2018 | Common Stock | 10,000 | 4,500 | D |
Explanation of responses
- F1This sale occurred pursuant to a 10b5-1 Trading Plan.